High-dose influenza vaccine: enhanced protection for the elderly
Introduction Seasonal influenza causes up to 50 million symptomatic cases and 15,000 – 70,000 deaths annually within the European Union. While influenza affects all age groups, adults aged ≥65 years disproportionately experience high rates of influenza-related hospitalizations and complications. Vac...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis Group
2025-12-01
|
| Edice: | Expert Review of Vaccines |
| Témata: | |
| On-line přístup: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2596673 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|